Ezra Y. Yacob - Mar 10, 2023 Form 4 Insider Report for EOG RESOURCES INC (EOG)

Role
Chairman & CEO, Director
Signature
Christina K. Byrom, attorney-in-fact for Ezra Y. Yacob
Stock symbol
EOG
Transactions as of
Mar 10, 2023
Transactions value $
-$671,238
Form type
4
Date filed
3/14/2023, 02:13 PM
Previous filing
Mar 1, 2023
Next filing
Apr 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOG Common Stock Options Exercise $1.53M +15.9K +14.41% $96.29 126K Mar 10, 2023 Direct
transaction EOG Common Stock Disposed to Issuer -$1.53M -13.4K -10.64% $113.96 113K Mar 10, 2023 Direct
transaction EOG Common Stock Tax liability -$110K -968 -0.86% $113.96 112K Mar 10, 2023 Direct
transaction EOG Common Stock Options Exercise $678K +9.03K +8.09% $75.09 121K Mar 10, 2023 Direct
transaction EOG Common Stock Disposed to Issuer -$678K -5.95K -4.93% $113.96 115K Mar 10, 2023 Direct
transaction EOG Common Stock Tax liability -$138K -1.21K -1.06% $113.96 114K Mar 10, 2023 Direct
transaction EOG Common Stock Options Exercise $225K +6.01K +5.3% $37.44 120K Mar 10, 2023 Direct
transaction EOG Common Stock Disposed to Issuer -$225K -1.98K -1.65% $113.96 118K Mar 10, 2023 Direct
transaction EOG Common Stock Tax liability -$181K -1.59K -1.35% $113.96 116K Mar 10, 2023 Direct
transaction EOG Common Stock Options Exercise $159K +3.19K +2.75% $49.86 119K Mar 10, 2023 Direct
transaction EOG Common Stock Disposed to Issuer -$159K -1.4K -1.17% $113.96 118K Mar 10, 2023 Direct
transaction EOG Common Stock Tax liability -$80.5K -706 -0.6% $113.96 117K Mar 10, 2023 Direct
transaction EOG Common Stock Options Exercise $1.04M +12.7K +10.87% $81.81 130K Mar 10, 2023 Direct
transaction EOG Common Stock Disposed to Issuer -$1.04M -9.14K -7.04% $113.96 121K Mar 10, 2023 Direct
transaction EOG Common Stock Tax liability -$161K -1.41K -1.17% $113.96 119K Mar 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOG Stock Appreciation Rights Options Exercise $0 -15.9K -100% $0.00* 0 Mar 10, 2023 Common Stock 15.9K $96.29 Direct F1
transaction EOG Stock Appreciation Rights Options Exercise $0 -9.03K -100% $0.00* 0 Mar 10, 2023 Common Stock 9.03K $75.09 Direct F2
transaction EOG Stock Appreciation Rights Options Exercise $0 -6.01K -66.6% $0.00 3.02K Mar 10, 2023 Common Stock 6.01K $37.44 Direct F3
transaction EOG Stock Appreciation Rights Options Exercise $0 -3.19K -66.6% $0.00 1.6K Mar 10, 2023 Common Stock 3.19K $49.86 Direct F4
transaction EOG Stock Appreciation Rights Options Exercise $0 -12.7K -33.3% $0.00 25.5K Mar 10, 2023 Common Stock 12.7K $81.81 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F2 The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F3 The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F4 The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the January 4, 2021 date of grant. The SARs granted will become fully exercisable on January 4, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F5 The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.